MANF Is Indispensable for the Proliferation and Survival of Pancreatic β Cells
Maria Lindahl,
Tatiana Danilova,
Erik Palm,
Päivi Lindholm,
Vootele Võikar,
Elina Hakonen,
Jarkko Ustinov,
Jaan-Olle Andressoo,
Brandon K. Harvey,
Timo Otonkoski,
Jari Rossi,
Mart Saarma
Affiliations
Maria Lindahl
Institute of Biotechnology, University of Helsinki, Viikinkaari 9, 00014 Helsinki, Finland; Corresponding author
Tatiana Danilova
Institute of Biotechnology, University of Helsinki, Viikinkaari 9, 00014 Helsinki, Finland
Erik Palm
Institute of Biotechnology, University of Helsinki, Viikinkaari 9, 00014 Helsinki, Finland
Päivi Lindholm
Institute of Biotechnology, University of Helsinki, Viikinkaari 9, 00014 Helsinki, Finland
Vootele Võikar
Neuroscience Center, University of Helsinki, Viikinkaari 4, 00014 Helsinki, Finland
Elina Hakonen
Research Program for Molecular Neurology and Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00014 Helsinki, Finland
Jarkko Ustinov
Research Program for Molecular Neurology and Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00014 Helsinki, Finland
Jaan-Olle Andressoo
Institute of Biotechnology, University of Helsinki, Viikinkaari 9, 00014 Helsinki, Finland
Brandon K. Harvey
Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA
Timo Otonkoski
Research Program for Molecular Neurology and Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00014 Helsinki, Finland; Children’s Hospital, Helsinki University Central Hospital, Haartmaninkatu 8, 00014 Helsinki, Finland
Jari Rossi
Institute of Biomedicine, Anatomy, University of Helsinki, Haartmaninkatu 8, 00014 Helsinki, Finland
Mart Saarma
Institute of Biotechnology, University of Helsinki, Viikinkaari 9, 00014 Helsinki, Finland
Summary: All forms of diabetes mellitus (DM) are characterized by the loss of functional pancreatic β cell mass, leading to insufficient insulin secretion. Thus, identification of novel approaches to protect and restore β cells is essential for the development of DM therapies. Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER)-stress-inducible protein, but its physiological role in mammals has remained obscure. We generated MANF-deficient mice that strikingly develop severe diabetes due to progressive postnatal reduction of β cell mass, caused by decreased proliferation and increased apoptosis. Additionally, we show that lack of MANF in vivo in mouse leads to chronic unfolded protein response (UPR) activation in pancreatic islets. Importantly, MANF protein enhanced β cell proliferation in vitro and overexpression of MANF in the pancreas of diabetic mice enhanced β cell regeneration. We demonstrate that MANF specifically promotes β cell proliferation and survival, thereby constituting a therapeutic candidate for β cell protection and regeneration. : Potent strategies for diabetes mellitus (DM) prevention and treatment are urgently needed. MANF is an endoplasmic reticulum stress-inducible protein, but its physiological role in mammals is currently unknown. Lindahl et al. now find that MANF-deficient mice develop diabetes. Importantly, MANF protein enhances β cell proliferation in vitro and pancreatic MANF overexpression in diabetic mice enhances β cell regeneration. Because MANF is expressed in human β cells, it might have therapeutic potential for diabetes treatment.